Iterative Health
Dan Wang is currently the VP of Finance & Operations at Iterative Health, where they have been working since June 2019. Prior to this, they have experience as an Investment Analyst at Amundi Pioneer and Barings. Dan obtained a Master of Business Administration degree from MIT Sloan School of Management in 2019, after completing their BA in Economics at Dartmouth College in 2014. They attended Thomas Jefferson High School for Science and Technology from 2006 to 2010.
This person is not in any teams
This person is not in any offices
Iterative Health
1 followers
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Employees
51-200